The rest is here: CohBar to Participate at ROTH Capital COVID-19 Therapeutics in Development Event
The rest is here: CohBar to Participate at ROTH Capital COVID-19 Therapeutics in Development Event
Originally posted here: Akari Therapeutics to Present Phase II Data from Bullous Pemphigoid Trial at European Academy of Dermatology and Venereology (EADV) Virtual Congress...
Go here to see the original: Galapagos’ R&D Roundtable showcases Toledo program
Read more here: Tiziana Life Sciences Announces Timetable of Demerger of Accustem (for holders of Tiziana ADRs)
Read more here: Indus Holdings, Inc. to Report Third Quarter 2020 Financial and Operational Results
See original here: Lumos Pharma to Report Third Quarter 2020 Financial Results and Host a Conference Call on November 10, 2020
Follow this link: Galera Therapeutics Announces Interim Data from Pilot Phase 1/2 Trial of GC4419 in Combination with Stereotactic Body Radiation Therapy Showed...
View post: Sanofi: Information concerning the total number of voting rights and shares - September 2020
Read the original: Aptose to Release Third Quarter Ended September 30, 2020 Financial Results and Hold Conference Call on November 10, 2020
Originally posted here: Opiant Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020
Recent Comments